Zinc Finger Proteins in Head and Neck Squamous Cell Carcinomas: ZNF540 May Serve as a Biomarker

Head and neck squamous cell carcinoma (HNSCC) is one of the ten most common cancers. Most cancer cases originate from alcohol and tobacco consumption. However, studies have demonstrated that human papillomavirus (<i>HPV</i>) infection, particularly <i>HPV-16</i>, may also sig...

Full description

Bibliographic Details
Main Authors: Joanna Sobocińska, Joanna Nowakowska, Sara Molenda, Anna Olechnowicz, Kacper Guglas, Joanna Kozłowska-Masłoń, Urszula Kazimierczak, Marta Machnik, Urszula Oleksiewicz, Anna Teresiak, Katarzyna Lamperska, Tomasz Kolenda
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Current Oncology
Subjects:
Online Access:https://www.mdpi.com/1718-7729/29/12/779
_version_ 1797460772966629376
author Joanna Sobocińska
Joanna Nowakowska
Sara Molenda
Anna Olechnowicz
Kacper Guglas
Joanna Kozłowska-Masłoń
Urszula Kazimierczak
Marta Machnik
Urszula Oleksiewicz
Anna Teresiak
Katarzyna Lamperska
Tomasz Kolenda
author_facet Joanna Sobocińska
Joanna Nowakowska
Sara Molenda
Anna Olechnowicz
Kacper Guglas
Joanna Kozłowska-Masłoń
Urszula Kazimierczak
Marta Machnik
Urszula Oleksiewicz
Anna Teresiak
Katarzyna Lamperska
Tomasz Kolenda
author_sort Joanna Sobocińska
collection DOAJ
description Head and neck squamous cell carcinoma (HNSCC) is one of the ten most common cancers. Most cancer cases originate from alcohol and tobacco consumption. However, studies have demonstrated that human papillomavirus (<i>HPV</i>) infection, particularly <i>HPV-16</i>, may also significantly influence disease progression. The KRAB-ZNF family of genes is involved in epigenetic suppression, and its involvement in carcinogenesis is the subject of extensive studies. The available literature data demonstrate that they may play different roles, both as tumor suppressors and oncogenes. In this study, six ZNF genes, <i>ZFP28</i>, <i>ZNF132</i>, <i>ZNF418</i>, <i>ZNF426</i>, <i>ZNF540</i>, and <i>ZNF880</i>, were tested using several in silico approaches based on the TCGA and GEO datasets. Our analyses indicate that the expression of the analyzed ZNFs was significantly downregulated in tumor tissues and depended on tumor localization. The expression levels of ZNFs differed between <i>HPV</i>-positive vs. <i>HPV</i>-negative patients depending on the clinical-pathological parameters. More specifically, the patients with higher levels of <i>ZNF418</i> and <i>ZNF540</i> showed better survival rates than those with a lower expression. In addition, the level of <i>ZNF540</i> expression in <i>HPV</i>-positive (<i>HPV(+)</i>) patients was higher than in <i>HPV</i>-negative (<i>HPV(−)</i>) patients (<i>p</i> < 0.0001) and was associated with better overall survival (OS). In conclusion, we demonstrate that <i>ZNF540</i> expression highly correlates with <i>HPV</i> infection, which renders <i>ZNF540</i> a potential biomarker for HNSCC prognosis and treatment.
first_indexed 2024-03-09T17:09:49Z
format Article
id doaj.art-e47e4bfac8e04bdd835fc56364220d31
institution Directory Open Access Journal
issn 1198-0052
1718-7729
language English
last_indexed 2024-03-09T17:09:49Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Current Oncology
spelling doaj.art-e47e4bfac8e04bdd835fc56364220d312023-11-24T14:13:26ZengMDPI AGCurrent Oncology1198-00521718-77292022-12-0129129896991510.3390/curroncol29120779Zinc Finger Proteins in Head and Neck Squamous Cell Carcinomas: ZNF540 May Serve as a BiomarkerJoanna Sobocińska0Joanna Nowakowska1Sara Molenda2Anna Olechnowicz3Kacper Guglas4Joanna Kozłowska-Masłoń5Urszula Kazimierczak6Marta Machnik7Urszula Oleksiewicz8Anna Teresiak9Katarzyna Lamperska10Tomasz Kolenda11Laboratory of Cancer Genetics, Greater Poland Cancer Center, Garbary 15, 61-866 Poznan, PolandDepartment of Cancer Immunology, Chair of Medical Biotechnology, Poznan University of Medical Sciences, 8 Rokietnicka Street, 60-806 Poznan, PolandDepartment of Cancer Immunology, Chair of Medical Biotechnology, Poznan University of Medical Sciences, 8 Rokietnicka Street, 60-806 Poznan, PolandDepartment of Cancer Immunology, Chair of Medical Biotechnology, Poznan University of Medical Sciences, 8 Rokietnicka Street, 60-806 Poznan, PolandLaboratory of Cancer Genetics, Greater Poland Cancer Center, Garbary 15, 61-866 Poznan, PolandLaboratory of Cancer Genetics, Greater Poland Cancer Center, Garbary 15, 61-866 Poznan, PolandDepartment of Cancer Immunology, Chair of Medical Biotechnology, Poznan University of Medical Sciences, 8 Rokietnicka Street, 60-806 Poznan, PolandDepartment of Cancer Immunology, Chair of Medical Biotechnology, Poznan University of Medical Sciences, 8 Rokietnicka Street, 60-806 Poznan, PolandDepartment of Cancer Immunology, Chair of Medical Biotechnology, Poznan University of Medical Sciences, 8 Rokietnicka Street, 60-806 Poznan, PolandLaboratory of Cancer Genetics, Greater Poland Cancer Center, Garbary 15, 61-866 Poznan, PolandLaboratory of Cancer Genetics, Greater Poland Cancer Center, Garbary 15, 61-866 Poznan, PolandLaboratory of Cancer Genetics, Greater Poland Cancer Center, Garbary 15, 61-866 Poznan, PolandHead and neck squamous cell carcinoma (HNSCC) is one of the ten most common cancers. Most cancer cases originate from alcohol and tobacco consumption. However, studies have demonstrated that human papillomavirus (<i>HPV</i>) infection, particularly <i>HPV-16</i>, may also significantly influence disease progression. The KRAB-ZNF family of genes is involved in epigenetic suppression, and its involvement in carcinogenesis is the subject of extensive studies. The available literature data demonstrate that they may play different roles, both as tumor suppressors and oncogenes. In this study, six ZNF genes, <i>ZFP28</i>, <i>ZNF132</i>, <i>ZNF418</i>, <i>ZNF426</i>, <i>ZNF540</i>, and <i>ZNF880</i>, were tested using several in silico approaches based on the TCGA and GEO datasets. Our analyses indicate that the expression of the analyzed ZNFs was significantly downregulated in tumor tissues and depended on tumor localization. The expression levels of ZNFs differed between <i>HPV</i>-positive vs. <i>HPV</i>-negative patients depending on the clinical-pathological parameters. More specifically, the patients with higher levels of <i>ZNF418</i> and <i>ZNF540</i> showed better survival rates than those with a lower expression. In addition, the level of <i>ZNF540</i> expression in <i>HPV</i>-positive (<i>HPV(+)</i>) patients was higher than in <i>HPV</i>-negative (<i>HPV(−)</i>) patients (<i>p</i> < 0.0001) and was associated with better overall survival (OS). In conclusion, we demonstrate that <i>ZNF540</i> expression highly correlates with <i>HPV</i> infection, which renders <i>ZNF540</i> a potential biomarker for HNSCC prognosis and treatment.https://www.mdpi.com/1718-7729/29/12/779HNSCC<i>HPV</i>KRAB-ZNFZNFbiomarkersTCGA
spellingShingle Joanna Sobocińska
Joanna Nowakowska
Sara Molenda
Anna Olechnowicz
Kacper Guglas
Joanna Kozłowska-Masłoń
Urszula Kazimierczak
Marta Machnik
Urszula Oleksiewicz
Anna Teresiak
Katarzyna Lamperska
Tomasz Kolenda
Zinc Finger Proteins in Head and Neck Squamous Cell Carcinomas: ZNF540 May Serve as a Biomarker
Current Oncology
HNSCC
<i>HPV</i>
KRAB-ZNF
ZNF
biomarkers
TCGA
title Zinc Finger Proteins in Head and Neck Squamous Cell Carcinomas: ZNF540 May Serve as a Biomarker
title_full Zinc Finger Proteins in Head and Neck Squamous Cell Carcinomas: ZNF540 May Serve as a Biomarker
title_fullStr Zinc Finger Proteins in Head and Neck Squamous Cell Carcinomas: ZNF540 May Serve as a Biomarker
title_full_unstemmed Zinc Finger Proteins in Head and Neck Squamous Cell Carcinomas: ZNF540 May Serve as a Biomarker
title_short Zinc Finger Proteins in Head and Neck Squamous Cell Carcinomas: ZNF540 May Serve as a Biomarker
title_sort zinc finger proteins in head and neck squamous cell carcinomas znf540 may serve as a biomarker
topic HNSCC
<i>HPV</i>
KRAB-ZNF
ZNF
biomarkers
TCGA
url https://www.mdpi.com/1718-7729/29/12/779
work_keys_str_mv AT joannasobocinska zincfingerproteinsinheadandnecksquamouscellcarcinomasznf540mayserveasabiomarker
AT joannanowakowska zincfingerproteinsinheadandnecksquamouscellcarcinomasznf540mayserveasabiomarker
AT saramolenda zincfingerproteinsinheadandnecksquamouscellcarcinomasznf540mayserveasabiomarker
AT annaolechnowicz zincfingerproteinsinheadandnecksquamouscellcarcinomasznf540mayserveasabiomarker
AT kacperguglas zincfingerproteinsinheadandnecksquamouscellcarcinomasznf540mayserveasabiomarker
AT joannakozłowskamasłon zincfingerproteinsinheadandnecksquamouscellcarcinomasznf540mayserveasabiomarker
AT urszulakazimierczak zincfingerproteinsinheadandnecksquamouscellcarcinomasznf540mayserveasabiomarker
AT martamachnik zincfingerproteinsinheadandnecksquamouscellcarcinomasznf540mayserveasabiomarker
AT urszulaoleksiewicz zincfingerproteinsinheadandnecksquamouscellcarcinomasznf540mayserveasabiomarker
AT annateresiak zincfingerproteinsinheadandnecksquamouscellcarcinomasznf540mayserveasabiomarker
AT katarzynalamperska zincfingerproteinsinheadandnecksquamouscellcarcinomasznf540mayserveasabiomarker
AT tomaszkolenda zincfingerproteinsinheadandnecksquamouscellcarcinomasznf540mayserveasabiomarker